Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: Final results of the PETHEMA ALL-AR-03 trial

1. Ribera, J.-M.
2. Oriol, A.
3. Morgades, M.
4. Montesinos, P.
5. Sarrà, J.
6. González-Campos, J.
7. Brunet, S.
8. Tormo, M.
9. Fernández-Abellán, P.
10. Guàrdia, R.
11. Bernal, M.-T.
12. Esteve, J.
13. Barba, P.
14. Moreno, M.-J.
15. Bermúdez, A.
16. Cladera, A.
17. Escoda, L.
18. García-Boyero, R.
19. Del Potro, E.
20. Bergua, J.
21. Amigo, M.-L.
22. Grande, C.
23. Rabuñal, M.-J.
24. Hernández-Rivas, J.-M.
25. Feliu, E.